When to initiate dialysis for end-stage kidney disease: evidence and challenges

Titi Chen, Vincent WS Lee and David C Harris
Med J Aust 2018; 209 (6): . || doi: 10.5694/mja18.00297
Published online: 17 September 2018



  • The decision about when to start dialysis for end-stage kidney disease (ESKD) is complex and is influenced by many factors. ESKD-related symptoms and signs are the most common indications for dialysis initiation. Creatinine-based formulae to estimate glomerular filtration rate (GFR) are inaccurate in patients with ESKD and, thus, the decision to start dialysis should not be based solely on estimated GFR (eGFR).
  • Early dialysis initiation (ie, at an eGFR > 10 mL/min/1.73 m2) is not associated with a morbidity and mortality benefit, as shown in the Initiating Dialysis Early and Late (IDEAL) study. This observation has been incorporated into the latest guidelines, which place greater emphasis on the assessment of patients’ symptoms and signs rather than eGFR. It is suggested that in asymptomatic patients with stage 5 chronic kidney disease, dialysis may be safely delayed until the eGFR is at least as low as 5–7 mL/min/1.73 m2 if there is careful clinical follow-up and adequate patient education.
  • The decision on when to start dialysis is even more challenging in older patients. Due to their comorbidities and frailty, dialysis initiation may be associated with worse outcomes and quality of life. Therefore, the decision to start dialysis in these patients should be carefully weighed against its risks, and conservative care should be considered in appropriate cases.
  • To optimise the decision-making process for dialysis initiation, patients need to be referred to a nephrologist in a timely fashion to allow adequate pre-dialysis care and planning. Dialysis initiation and its timing should be a shared decision between physician, patients and family members, and should be tailored to the individual patient’s needs.


  • University of Sydney, Sydney, NSW


Competing interests:

No relevant disclosures.

  • 1. Wong SP, Vig EK, Taylor JS, et al. Timing of initiation of maintenance dialysis: a qualitative analysis of the electronic medical records of a national cohort of patients from the Department of Veterans Affairs. JAMA Intern Med 2016; 176: 228-235.
  • 2. Daugirdas JT, Blake PG, Ing TS, et al. Handbook of dialysis. Philadelphia: Wolters Kluwer Health; 2014.
  • 3. Hakim RM, Lazarus JM. Initiation of dialysis. J Am Soc Nephrol 1995; 6: 1319-1328.
  • 4. Evans M, van Stralen KJ, Schon S, et al. Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease. Nephrol Dial Transplant 2013; 28: 2518-2526.
  • 5. Berns JS. Clinical decision making in a patient with stage 5 CKD--is eGFR good enough? Clin J Am Soc Nephrol 2015; 10: 2065-2072.
  • 6. White CA, Akbari A. The estimation, measurement, and relevance of the glomerular filtration rate in stage 5 chronic kidney disease. Semin Dial 2011; 24: 540-549.
  • 7. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
  • 8. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
  • 9. O’Hare AM, Choi AI, Boscardin WJ, et al. Trends in timing of initiation of chronic dialysis in the United States. Arch Intern Med 2011; 171: 1663-1669.
  • 10. Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008; 51(1 Suppl 1): S1-320.
  • 11. Australian and New Zealand Dialysis and Transplant Registry. Chapter 1. Incidence of end stage kidney disease. In: ANZDATA. 39th annual ANZDATA report [website]. Adelaide: ANZDATA; 2017. (viewed June 2018).
  • 12. Bonomini V, Feletti C, Scolari MP, et al. Benefits of early initiation of dialysis. Kidney Int Suppl 1985; 17: S57-59.
  • 13. Nolph KD. Rationale for early incremental dialysis with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1998; 13 Suppl 6: 117-119.
  • 14. Rosansky S, Glassock RJ, Clark WF. Early start of dialysis: a critical review. Clin J Am Soc Nephrol 2011; 6: 1222-1228.
  • 15. Rosansky SJ, Eggers P, Jackson K, et al. Early start of hemodialysis may be harmful. Arch Intern Med 2011; 171: 396-403.
  • 16. Clark WF, Na Y, Rosansky SJ, et al. Association between estimated glomerular filtration rate at initiation of dialysis and mortality. CMAJ 2011; 183: 47-53.
  • 17. Wright S, Klausner D, Baird B, et al. Timing of dialysis initiation and survival in ESRD. Clin J Am Soc Nephrol 2010; 5: 1828-1835.
  • 18. Sawhney S, Djurdjev O, Simpson K, et al. Survival and dialysis initiation: comparing British Columbia and Scotland registries. Nephrol Dial Transplant 2009; 24: 3186-3192.
  • 19. Hwang SJ, Yang WC, Lin MY, et al. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan. Nephrol Dial Transplant 2010; 25: 2616-2624.
  • 20. Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010; 363: 609-619.
  • 21. Perl J, Bargman JM. The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis 2009; 53: 1068-1081.
  • 22. Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int 2006; 69: 1726-1732.
  • 23. McIntyre CW, Rosansky SJ. Starting dialysis is dangerous: how do we balance the risk? Kidney Int 2012; 82: 382-387.
  • 24. Chan KE, Maddux FW, Tolkoff-Rubin N, et al. Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol 2011; 6: 2642-2649.
  • 25. Schmidt RJ, Goldman RS, Germain M. Pursuing permanent hemodialysis vascular access in patients with a poor prognosis: juxtaposing potential benefit and harm. Am J Kidney Dis 2012; 60: 1023-1031.
  • 26. Drew DA, Lok CE, Cohen JT, et al. Vascular access choice in incident hemodialysis patients: a decision analysis. J Am Soc Nephrol 2015; 26: 183-191.
  • 27. Rosansky SJ, Cancarini G, Clark WF, et al. Dialysis initiation: what’s the rush? Semin Dial 2013; 26: 650-657.
  • 28. Miskulin DC, Abebe KZ, Chapman AB, et al. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study. Am J Kidney Dis 2014; 63: 214-226.
  • 29. Wong MG, Pollock CA, Cooper BA, et al. Association between GFR estimated by multiple methods at dialysis commencement and patient survival. Clin J Am Soc Nephrol 2014; 9: 135-142.
  • 30. Harris A, Cooper BA, Li JJ, et al. Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis 2011; 57: 707-715.
  • 31. Crews DC, Scialla JJ, Liu J, et al. Predialysis health, dialysis timing, and outcomes among older United States adults. J Am Soc Nephrol 2014; 25: 370-379.
  • 32. Sjolander A, Nyren O, Bellocco R, et al. Comparing different strategies for timing of dialysis initiation through inverse probability weighting. Am J Epidemiol 2011; 174: 1204-1210.
  • 33. Crews DC, Scialla JJ, Boulware LE, et al. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis 2014; 63: 806-815.
  • 34. Rivara MB, Mehrotra R. Timing of dialysis initiation: what has changed since IDEAL? Semin Nephrol 2017; 37: 181-193.
  • 35. Pollock CA, Cooper BA, Harris DC. When should we commence dialysis? The story of a lingering problem and today’s scene after the IDEAL study. Nephrol Dial Transplant 2012; 27: 2162-2166.
  • 36. National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 2015; 66: 884-930.
  • 37. Nesrallah GE, Mustafa RA, Clark WF, et al. Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis. CMAJ 2014; 186: 112-117.
  • 38. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150.
  • 39. Tattersall J, Dekker F, Heimburger O, et al. When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study. Nephrol Dial Transplant 2011; 26: 2082-2086.
  • 40. United States Renal Data System. 2017 USRDS annual data report: epidemiology of kidney disease in the United States [website]. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2017. (viewed June 2018).
  • 41. Bargman JM. Timing of initiation of RRT and modality selection. Clin J Am Soc Nephrol 2015; 10: 1072-1077.
  • 42. Davison SN. The ethics of end-of-life care for patients with ESRD. Clin J Am Soc Nephrol 2012; 7: 2049-2057.
  • 43. Jassal SV, Watson D. Dialysis in late life: benefit or burden. Clin J Am Soc Nephrol 2009; 4: 2008-2012.
  • 44. Morton RL, Webster AC, McGeechan K, et al. Conservative management and end-of-life care in an Australian cohort with ESRD. Clin J Am Soc Nephrol 2016; 11: 2195-2203.
  • 45. Cohen LM, Germain MJ. Caregiver burden and hemodialysis. Clin J Am Soc Nephrol 2014; 9: 840-842.
  • 46. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999; 33: 235-252.
  • 47. Jesudason S, Grace BS, McDonald SP. Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. Clin J Am Soc Nephrol 2014; 9: 143-149.
  • 48. Hladunewich MA, Hou S, Odutayo A, et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J Am Soc Nephrol 2014; 25: 1103-1109.
  • 49. Asamiya Y, Otsubo S, Matsuda Y, et al. The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age. Kidney Int 2009; 75: 1217-1222.
  • 50. Australian Institute of Health and Welfare 2011. Chronic kidney disease in Aboriginal and Torres Strait Islander people 2011 (AIHW CatNo. PHD151). Canberra: AIHW.
  • 51. Australian and New Zealand Dialysis and Transplant Registry. Chapter 12. End stage kidney disease among Indigenous peoples of Australia and New Zealand. In: ANZDATA. 39th Annual ANZDATA report [website]. Adelaide: ANZDATA; 2017. (viewed June 2018).
  • 52. Lawton PD, Cunningham J, Gray NA, et al. Survival of Indigenous Australians receiving renal replacement therapy: closing the gap? Med J Aust 2015; 202: 297. <MJA full text>
  • 53. Hoy WE. Kidney disease in Aboriginal Australians: a perspective from the Northern Territory. Clin Kidney J 2014; 7: 524-530.
  • 54. Perl J, Zhang J, Gillespie B, et al. Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2012; 27: 4464-4472.
  • 55. Kukla A, Adulla M, Pascual J, et al. CKD stage-to-stage progression in native and transplant kidney disease. Nephrol Dial Transplant 2008; 23: 693-700.
  • 56. Molnar MZ, Ichii H, Lineen J, et al. Timing of return to dialysis in patients with failing kidney transplants. Semin Dial 2013; 26: 667-674.
  • 57. Chen T, Harris DC. Challenges of chronic kidney disease prevention. Med J Aust 2015; 203: 209-210.
  • 58. Baer G, Lameire N, Van Biesen W. Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions. NDT Plus 2010; 3: 17-27.
  • 59. Van Biesen W, De Vecchi A, Dombros N, et al. The referral pattern of end-stage renal disease patients and the initiation of dialysis: a European perspective. Perit Dial Int 1999; 19 Suppl 2: S273-275.
  • 60. Goransson LG, Bergrem H. Consequences of late referral of patients with end-stage renal disease. J Intern Med 2001; 250: 154-159.
  • 61. Australian Kidney Foundation. Chronic kidney disease (CKD) management in general practice, 3rd ed. Melbourne: Kidney Health Australia; 2015. (viewed June 2018).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.